Cardiac related death in thalassaemia major

Time trend and risk factors in a large Greek Unit

Giorgos Chouliaras, Constantin Yiannoutsos, Vasilios Berdoukas, Vassilios Ladis

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Cardiac complications are the leading cause of death in thalassaemic patients (TM) worldwide. Improved management protocols including new chelators and imaging have reduced cardiac-related deaths but also require more advanced analytical methods to reflect temporal fluctuations in mortality risk. Objectives: To evaluate time patterns of risk of cardiac death in TM patients according to birth cohort, gender and degree of haemosiderosis and to apply new flexible methods of analysis that may allow assessment of trends in risks as affected by innovations in management. Design and methods: Cardiac-free survival and time trend of the risk of cardiac-related death were assessed in 648 transfusion-depended thalassaemic patients (48.3% females) managed in a single unit located in Athens, Greece. Patients were classified according to birth cohort (prior or after 1/1/1975) and according to the severity of haemosiderosis (mild, moderate and severe) as estimated by the mean ferritin levels during the last 5 yr of follow-up. Results: The median time of observation was 27.8 yr and 84 cardiac deaths were recorded. A parametric analysis predicted a non-monotonous time pattern for the cardiac risk with an initial increasing phase until the fourth decade of life followed by a drop off in deaths. Women have 23% longer life expectancy than men (P = 0.010) while patients born after 1975 die of heart complications at an older age compared to those born prior to 1975 (time ratio = 1.34, P = 0.003). Patients with mild and moderate haemosiderosis lived 89% (P < 0.001) and 43% (P < 0.001) longer, respectively, compared with patients with severe haemosiderosis. Conclusions: These results on risk of death in thalassaemia, accord with expectations. This type of analysis will be useful in the future when the expected impact of cardiac MRI with appropriate tailoring of chelation therapy using all current and future options will modify the pattern of risk of cardiac death observed to date.

Original languageEnglish
Pages (from-to)381-387
Number of pages7
JournalEuropean Journal of Haematology
Volume82
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

beta-Thalassemia
Hemosiderosis
Parturition
Chelation Therapy
Thalassemia
Greece
Ferritins
Chelating Agents
Life Expectancy
Cause of Death
Observation
Survival
Mortality

Keywords

  • Cardiac death
  • Haemosiderosis
  • Survival
  • Thalassaemia
  • Time trend

ASJC Scopus subject areas

  • Hematology

Cite this

Cardiac related death in thalassaemia major : Time trend and risk factors in a large Greek Unit. / Chouliaras, Giorgos; Yiannoutsos, Constantin; Berdoukas, Vasilios; Ladis, Vassilios.

In: European Journal of Haematology, Vol. 82, No. 5, 05.2009, p. 381-387.

Research output: Contribution to journalArticle

Chouliaras, Giorgos ; Yiannoutsos, Constantin ; Berdoukas, Vasilios ; Ladis, Vassilios. / Cardiac related death in thalassaemia major : Time trend and risk factors in a large Greek Unit. In: European Journal of Haematology. 2009 ; Vol. 82, No. 5. pp. 381-387.
@article{6a4ed5fa53704cddbd2add3cc0d4b41f,
title = "Cardiac related death in thalassaemia major: Time trend and risk factors in a large Greek Unit",
abstract = "Background: Cardiac complications are the leading cause of death in thalassaemic patients (TM) worldwide. Improved management protocols including new chelators and imaging have reduced cardiac-related deaths but also require more advanced analytical methods to reflect temporal fluctuations in mortality risk. Objectives: To evaluate time patterns of risk of cardiac death in TM patients according to birth cohort, gender and degree of haemosiderosis and to apply new flexible methods of analysis that may allow assessment of trends in risks as affected by innovations in management. Design and methods: Cardiac-free survival and time trend of the risk of cardiac-related death were assessed in 648 transfusion-depended thalassaemic patients (48.3{\%} females) managed in a single unit located in Athens, Greece. Patients were classified according to birth cohort (prior or after 1/1/1975) and according to the severity of haemosiderosis (mild, moderate and severe) as estimated by the mean ferritin levels during the last 5 yr of follow-up. Results: The median time of observation was 27.8 yr and 84 cardiac deaths were recorded. A parametric analysis predicted a non-monotonous time pattern for the cardiac risk with an initial increasing phase until the fourth decade of life followed by a drop off in deaths. Women have 23{\%} longer life expectancy than men (P = 0.010) while patients born after 1975 die of heart complications at an older age compared to those born prior to 1975 (time ratio = 1.34, P = 0.003). Patients with mild and moderate haemosiderosis lived 89{\%} (P < 0.001) and 43{\%} (P < 0.001) longer, respectively, compared with patients with severe haemosiderosis. Conclusions: These results on risk of death in thalassaemia, accord with expectations. This type of analysis will be useful in the future when the expected impact of cardiac MRI with appropriate tailoring of chelation therapy using all current and future options will modify the pattern of risk of cardiac death observed to date.",
keywords = "Cardiac death, Haemosiderosis, Survival, Thalassaemia, Time trend",
author = "Giorgos Chouliaras and Constantin Yiannoutsos and Vasilios Berdoukas and Vassilios Ladis",
year = "2009",
month = "5",
doi = "10.1111/j.1600-0609.2009.01218.x",
language = "English",
volume = "82",
pages = "381--387",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Cardiac related death in thalassaemia major

T2 - Time trend and risk factors in a large Greek Unit

AU - Chouliaras, Giorgos

AU - Yiannoutsos, Constantin

AU - Berdoukas, Vasilios

AU - Ladis, Vassilios

PY - 2009/5

Y1 - 2009/5

N2 - Background: Cardiac complications are the leading cause of death in thalassaemic patients (TM) worldwide. Improved management protocols including new chelators and imaging have reduced cardiac-related deaths but also require more advanced analytical methods to reflect temporal fluctuations in mortality risk. Objectives: To evaluate time patterns of risk of cardiac death in TM patients according to birth cohort, gender and degree of haemosiderosis and to apply new flexible methods of analysis that may allow assessment of trends in risks as affected by innovations in management. Design and methods: Cardiac-free survival and time trend of the risk of cardiac-related death were assessed in 648 transfusion-depended thalassaemic patients (48.3% females) managed in a single unit located in Athens, Greece. Patients were classified according to birth cohort (prior or after 1/1/1975) and according to the severity of haemosiderosis (mild, moderate and severe) as estimated by the mean ferritin levels during the last 5 yr of follow-up. Results: The median time of observation was 27.8 yr and 84 cardiac deaths were recorded. A parametric analysis predicted a non-monotonous time pattern for the cardiac risk with an initial increasing phase until the fourth decade of life followed by a drop off in deaths. Women have 23% longer life expectancy than men (P = 0.010) while patients born after 1975 die of heart complications at an older age compared to those born prior to 1975 (time ratio = 1.34, P = 0.003). Patients with mild and moderate haemosiderosis lived 89% (P < 0.001) and 43% (P < 0.001) longer, respectively, compared with patients with severe haemosiderosis. Conclusions: These results on risk of death in thalassaemia, accord with expectations. This type of analysis will be useful in the future when the expected impact of cardiac MRI with appropriate tailoring of chelation therapy using all current and future options will modify the pattern of risk of cardiac death observed to date.

AB - Background: Cardiac complications are the leading cause of death in thalassaemic patients (TM) worldwide. Improved management protocols including new chelators and imaging have reduced cardiac-related deaths but also require more advanced analytical methods to reflect temporal fluctuations in mortality risk. Objectives: To evaluate time patterns of risk of cardiac death in TM patients according to birth cohort, gender and degree of haemosiderosis and to apply new flexible methods of analysis that may allow assessment of trends in risks as affected by innovations in management. Design and methods: Cardiac-free survival and time trend of the risk of cardiac-related death were assessed in 648 transfusion-depended thalassaemic patients (48.3% females) managed in a single unit located in Athens, Greece. Patients were classified according to birth cohort (prior or after 1/1/1975) and according to the severity of haemosiderosis (mild, moderate and severe) as estimated by the mean ferritin levels during the last 5 yr of follow-up. Results: The median time of observation was 27.8 yr and 84 cardiac deaths were recorded. A parametric analysis predicted a non-monotonous time pattern for the cardiac risk with an initial increasing phase until the fourth decade of life followed by a drop off in deaths. Women have 23% longer life expectancy than men (P = 0.010) while patients born after 1975 die of heart complications at an older age compared to those born prior to 1975 (time ratio = 1.34, P = 0.003). Patients with mild and moderate haemosiderosis lived 89% (P < 0.001) and 43% (P < 0.001) longer, respectively, compared with patients with severe haemosiderosis. Conclusions: These results on risk of death in thalassaemia, accord with expectations. This type of analysis will be useful in the future when the expected impact of cardiac MRI with appropriate tailoring of chelation therapy using all current and future options will modify the pattern of risk of cardiac death observed to date.

KW - Cardiac death

KW - Haemosiderosis

KW - Survival

KW - Thalassaemia

KW - Time trend

UR - http://www.scopus.com/inward/record.url?scp=64249113129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249113129&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2009.01218.x

DO - 10.1111/j.1600-0609.2009.01218.x

M3 - Article

VL - 82

SP - 381

EP - 387

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 5

ER -